NCT05595200Recruiting
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
Source: ClinicalTrials.gov · Last updated 26 Oct 2026
Brief summary (registry, in English)
The investigators propose a prospective, observational study to determine the impact of OSA and associated physiological parameters on clinical outcomes in patients with pulmonary hypertension. The prevalence, phenotypes, and predictors of OSA in the setting of pulmonary hypertension will also be investigated. Adult patients diagnosed with pulmonary hypertension by right heart catheterization are eligible. Recruited patients will undergo an overnight cardiorespiratory study using a Level III portable device before hospital discharge. The cardiorespiratory tracings during sleep will be analyzed and audited by a certified sleep physician. The patients will be divided into two groups based on the apnea-hypopnea index (AHI): OSA (AHI ≥ 5) and non-OSA (AHI\<5) groups. Hypoxemic parameters such as time percentage spent with oxygen saturation below 90% and nadir oxygen saturation were all collected. Baseline clinical characteristics, such as the Epworth sleepiness scales, were also obtained. The primary endpoint of this study was clinical worsening (CW), defined as the composite event of a reduction in exercise capacity, worsening in World Health Organization functional class, non-elective hospitalization for pulmonary hypertension, or all-cause mortality. Secondary endpoints include individual outcomes of clinical worsening and all-cause mortality.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 480 (estimated)
- First submitted
- 22 Oct 2022
- Start date
- May 2020
- Primary completion date
- Dec 2028
- Lead sponsor
- Chinese Pulmonary Vascular Disease Research Group
- NCT number
- NCT05595200
What you commit to
- Study type: Observational
- Planned participants: 480
- From May 2020 to the primary completion date, Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous treatment for sleep-disordered breathing
Other
- Pregnancy
- Central sleep apnea
- Unavailable or incomplete sleep data
- Requiring nocturnal oxygen supplementation
Who the study is looking for
- Aged ≥18 years old
- Diagnosed with pulmonary hypertension by right heart catheterization
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Center for Respiratory and Pulmonary Vascular Diseases, Fuwai hospital, CAMS & PUMC Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.